RETRACTED: Parthenolide alleviates cognitive dysfunction and neurotoxicity via regulation of AMPK/GSK3β(Ser9)/Nrf2 signaling pathway - 04/12/23
, Xia Zhao b, d, ⁎ , Guang Liang a, b, ⁎ Résumé |
This article has been retracted: please see Elsevier policy on article correction, retraction and removal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal).
This article has been retracted at the request of the Editor.
Post-publication, an investigation conducted on behalf of the journal by Elsevier’s Research Integrity & Publishing Ethics team identified a concern around the authenticity of the following figures/image panels:
- | Figure 2 Western blot Panel A, P-GSK-3 protein and Figure 6 Panel F, P-GSK-3 protein appear to depict the same source image but are described as representing different experimental samples. |
- | Figure 6F Western blot for T-GSK-3 protein Panel repeats 1 and 3 appear to depict the same source image but are described as representing different experimental samples. |
- | Figure 6F Western blot for p-AMPK protein Panel repeats 2 and 3 appear to depict the same source image but are described as representing different experimental samples. |
- | Figure 2A Western blot for T-GASK-3 protein Panel repeats 1 and Figure 6F Western blot for T-GASK-3 protein Panel repeat 3 appear to depict the same source image but are described as representing different experimental samples. |
The authors were requested to provide comment on these concerns, as well as the original unprocessed image files to aid investigation.
It was felt that the explanation provided were unsatisfactory in resolving these concerns.
The Editor has lost confidence in the results and conclusions of the article and has determined it should be retracted.
The authors disagree with retraction and dispute the grounds for it.
Le texte complet de cet article est disponible en PDF.
Vol 169
Article 115909- décembre 2023 Retour au numéro
Article précédent
- A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide
- Stefan A.J. Buck, Marinda Meertens, Frederiek M.F. van Ooijen, Esther Oomen-de Hoop, Evert de Jonge, Marieke J.H. Coenen, Andries M. Bergman, Stijn L.W. Koolen, Ronald de Wit, Alwin D.R. Huitema, Ron H.N. van Schaik, Ron H.J. Mathijssen
- Targeting kinase ITK treats autoimmune arthritis via orchestrating T cell differentiation and function
- Ye Chen, Rongzhen Liang, Xiaoyi Shi, Rong Shen, Liu Liu, Yan Liu, Youqiu Xue, Xinghua Guo, Junlong Dang, Donglan Zeng, Feng Huang, Jianbo Sun, Jingwen Zhang, Julie Wang, Nancy Olsen, Avery August, Weishan Huang, Yunfeng Pan, Song Guo Zheng
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?